Serum bridging molecules drive candidal invasion of human but not mouse endothelial cells is a research paper published in PLoS Pathogens (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: R01AI124566
National Institute of Dental and Craniofacial Research
Grant: R00DE026856
National Institute of Allergy and Infectious Diseases
Grant: R01AI141202
National Center for Advancing Translational Sciences
Grant: UL1TR001881
National Institutes of Health
Grant: 5R01AI141202-04
Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens
National Institutes of Health
Grant: 5R01AI124566-03
Endothelial invasion by yeast-phase Candida
National Institutes of Health
Grant: 4R00DE026856-03
Novel Candida albicans host receptors during infection and immune response
National Institutes of Health
Grant: 3UL1TR001881-01S2
UCLA Clinical Translational Science Institute
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals